The tyrosinase is a bifunctional, copper-containing enzyme widely distributed in the phylogenetic tree. This enzyme is involved in the production of melanin and some other pigments in humans, animals and plants, including skin pigmentations in mammals, and browning process in plants and vegetables. Therefore, enzyme inhibitors has been under the attention of the scientist community, due to its broad applications in food, cosmetic, agricultural and medicinal fields, to avoid the undesirable effects of abnormal melanin overproduction. However, the research of novel chemical with antityrosinase activity demands the use of more efficient tools to speed up the tyrosinase inhibitors discovery process. This chapter is focused in the different components of a predictive modeling workflow for the identification and prioritization of potential new compounds with activity against the tyrosinase enzyme. In this case, two structure chemical libraries Spectrum Collection and Drugbank are used in this attempt to combine different virtual screening data mining techniques, in a sequential manner helping to avoid the usually expensive and time consuming traditional methods. Some of the sequential steps summarize here comprise the use of drug-likeness filters, similarity searching, classification and potency QSAR multiclassifier systems, modeling molecular interactions systems, and similarity/diversity analysis. Finally, the methodologies showed here provide a rational workflow for virtual screening hit analysis and selection as a promissory drug discovery strategy for use in target identification phase.
INTRODUCTION

Tyrosinase
(monophenol monooxygenasse; EC 1.1.4.18.1) is a metalloenzyme oxidase widely distributed in the phylogenetic tree. This enzyme catalyze the two first steps of melanin synthesis pathway, by the hydroxylation of the L-tyrosine to 3,4-dihydroxyphenylalanine L-DOPA (monophenolase activity), and the posterior oxidation to dopaquinone (diphenolase activity) [1] . Because its main role in melanogenesis, abnormal tyrosinase regulation it is related with some skin diseases such as hyperpigmentation, melasma (acquired hyperpigmentation), post in ammatory melanoderma, solar lentigo, etc [2] [3] [4] . Hence, tyrosinase inhibitors have been used largely as depigmenting agents for treatment of these pigmentation disorders [5] [6] [7] . In recent times, besides QSAR methodologies, there are other data mining techniques introduced in drug discovery with high accuracy levels [8] . This successful data integration is a complex theme in the desktop today´s researchers. In this sense the current drug discovery scenarios are introducing standard workflow for screening structural chemical libraries [9] . This issue presents advantages because compounds could be obtained by the direct purchase from the owners avoiding the time-consuming of synthesis or isolation process [10] . Moreover, in the last times, the campaigns associated with massive virtual HTS are continuously increasing are gaining on accuracy in the prioritization process of chemicals, due to the introduction of several ligand and structure based methodologies [11] [12] .
Therefore, to manage larger compounds libraries and cover the expectations of the drug discovery process, in silico virtual screening and computer-aided drug design have become increasingly important [13] . In our research group, this approach has been applied in the discovery of novel tyrosinase inhibitors (TIs) as cycloartane [14] [15] , diterpenoidal alkaloids [16] , tetraketones [17] , coumarin [18] , and so on. In these studies, the classification QSAR-based virtual screening (VS) has been employed for in-house congeneric chemical libraries of different laboratories to identify TIs from inactives. Latter, new class of QSAR models named potency models [19] [20] were developed. The last models could be used as a cascade system together with the classification models for more complete description of tyrosinase inhibitory activity. Besides, this type of models helps to identify true positives and make an adequate process of prioritization of compounds. In recent work, all these models were assembled in different multi-classifier systems (MCSs) that improved the performance of QSAR methods [21] .
By this means, in this chapter we present a procedure of combining these and others different VS strategies in the computational research for the selection/identification of novel tyrosinase inhibitors. This framework was employed with efficacy to discover new chemical entities with antityrosinase activity. Finally, is important to stand out that the different virtual screening approaches mentioned comprises: drug-likeness filters, similarity searching, classification and potency QSAR multi-classifier systems, molecular docking studies, and post-processing procedures as strategies; that were assessed in a sequential manner over the Spectrum Collection and Drugbank databases.
TWO STRUCTURE CHEMICAL LIBRARIES: SPECTRUM COLLECTION AND DRUGBANK
The ascending grown of computational resources have brought a rapid increasing of structural chemical databases either online or repository company. The more interesting examples are the huge ZINC and ChemSpider databases, comprising 13 million and 26 million of compounds, respectively. This two chemical data sources are included between the main sixty-four free databases nowadays [22] . Therefore, the huge structural chemical database screening is becoming one of the hotter topics in compound retrieve using any QSAR, ligand or structure data mining procedures. In this sense, some authors have included interesting updated reviews about this topic [23] [24] . By this mean here we presented the results obtained over the Spectrum collection (http://www.msdiscovery.com/spectrum.html) and Drugbank (www.drugbank.ca), which consists of 2 000 and 6 827 compounds, respectively, that were screened using a sequential strategy for virtual screening looking for potential therapeutic chemicals for the treatment of hyper-pigmentation disorders. A owchart depicting the various steps of virtual screening including database ltration, similarity searching, QSAR modeling, docking and clustering studies to prioritize the virtual hits is shown in (Fig. 1) .
This Fig. (1) displays the virtual screening stepwise workflow which resulted in the discovery of novel scaffolds against the tyrosinase enzyme. The protocol was based in the computational hierarchy of each filter, the consuming CPU time and the complexity of input information for each step. This hierarchical procedure allows reducing the number of selected compounds (retrieved as novel TIs) gradually after each filter. This mentioned strategy was employed to screen virtually two databases (Spectrum Collection and Drugbank).
By other way, many of the chemical libraries as the case of PubChem [25] on-line database are web-based systems with well recognize facilities to do some pre-processing tasks in an easy way. This is the also the case Spectrum collection and Drugbank were some drug-likeness filters or similarity searching methods are implemented as tools for search and retrieving. Therefore some of these services were used in these studies.
DRUG-LIKENESS FILTERS
The term "druglike" [26] [27] [28] [29] is used for pharmaceutical research to describe molecules with properties that fall within the boundaries delineated by the wide majority of pharmaceutical agents. This process is associated with the many possible molecular properties that most directly influence the drug-like properties of a molecule in some specific type of research. Lipinski et al. [30] defined the so-called "rule of five" (sometimes abbreviated as RoF) in an effort to solve this question. The main steps of this concept is the examination of different parameters such as the number of rotatable bonds (nRotB), polar surface area (PSA), log D, and counts of nitrogen and oxygen atoms in an effort to define easily calculated properties that will be predictive of a favorable outcome and established mayor cutoff for these physi- cal-chemical properties and others [31] [32] [33] [34] [35] . However the threshold of Lipinski seems very rigid in occasions. Hence some scientist in this field have stand out and proposed other diverse boundaries and criteria of drug-likeness filters [36] . Taking this into consideration, in our work we applied superior limits of all these filters. In our case, a compound was not taken into consideration in the next steps if it has the molecular weight (MW) above 700 g/mol; the computed octanol-water partition coefficient CLogP higher than 7; the number of hydrogen bond donors (nHBDon) above 5 and acceptors (nHBAc) above 10; the number of rotatable bonds (nRotB) higher than 10 and a polar surface area (PSA) above 140 Å 2 . All these descriptors were calculated with our in house TOMOCOMD-CARDD (acronym for TOpological MOlecular COMputational Design -Computed-Aided 'Rational' Drug Design) software. These molecular descriptors are implemented in a new module (DESPOOLs, acronym of DEScriptor POOLs) of our program [37] that offers calculations of the several 0-3D indices, which are calculated mainly using The Chemistry Development Kit [38] . By using the defined way above we proceed to the first filtering consisting in the application of the criteria describe above on the Spectrum collection database (http://www.msdiscovery.com/spectrum.html). This first step also consists of reducing the number of chemicals (negative design) employing the Drug-likeness filters. These are simple, fast and also allow "optimizing" in some way simultaneously the potency and the pharmacokinetic [39] . So, we further sorted these 2 000 compounds using the superior boundaries of all filters reported in the literature and nally 1 394 compounds were further considered for the next step.
SIMILARITY SEARCHING
Similarity searching identifies those database molecules that are most similar to reference structures, using some quantitative definition of intermolecular structural similarity. The reference structures and the molecules in the database are characterized by one or more molecular descriptors. Their comparisons allow the calculation of a similarity measurement between the reference structure and each of the database structures, and the latter ones are then sorted into order of decreasing similarity with the target. The output from the search is a ranked list in which the structures that are calculated to be most similar to the reference structure are located at the top of the list. These chemicals will be those that have the greatest probability of being of interest to the user, given an appropriate measure of intermolecular structural similarity. The similarity methods are extremely useful at the beginning of a drug discovery project, because it needs little information about the target and only few known active compounds. Moreover, the implementations of similarity methods are generally computationally inexpensive, so searching large databases can be routinely performed. The result of this step is a focused library, since all included compounds present common features a reference compounds. In our case the data fusion method [40] was applied. . In Table 1 , the structures of reference compounds were given. A hierarchical cluster analysis, k-NNCA, was executed to visualize the distribution of reference compounds in different groups. In Fig. (2) , a dendogram for these compounds is shown. It can be seen, there is great structural diversity among these chemicals, which represent different molecular subsystems important for the tyrosinase activity.
The set of 15 strong tyrosinase inhibitors of diverse structures was selected as reference compounds. The molecular structures of these chemicals are given in Table 1 .
The MACCS fingerprints [41] were calculated to characterize reference structures and the ones of the database employing the program TOMOCOMD-CARDD software. These fingerprint are implemented in a new module (MOLFIP, acronym of MOLecular FIngerPrints) of our program [37] that offers calculations of the several fingerprints, which are calculated mainly using The Chemistry Development Kit [38] . The Tanimoto coefficient [42] , commonly used for binary data, was computed to establish the metrics of intermolecular comparison (each compound with every other in its activity class). A specific database molecule appears at rank position r ij (1 i n, 1 j 15) with a similarity measurement (scores), s j against every reference structure. We used the fusion rule MAX for combining the similarity scores, so the final fused score was established as shown in Equation 1.
Later, each molecule of the database was sorted by its fused score, s f . The similarly active compounds in the top 30% of highest ranked data set compounds were retrieved for the next step. For the case of the Spectrum collection database structures this procedure was applied resulting in the elimination of 1285 molecules. The remaining 109 compounds are similar in some way to one of 15 reference compounds (positive design).
The Drugbank database (www.drugbank.ca) of 6 827 drugs was also screened using a similar procedure as above. In this case, first the similarity searching (data fusion by maximum score using 15 strong TIs as reference structures) was applied, because DrugBank offers this option in the management of its search database. By this procedure were eliminated 6659 compounds representing the 97.54% of the chemicals in the database. The repeated or reported against the tyrosinase compounds were removed and the remaining ones were ltered using Druglikeness criteria mentioned in the section above. From this, 131 compounds were selected and considered for the next step.
MULTICLASSIFIERS GUIDED BY QSAR MODELS
In recent times, Quantitative Structure-Activity Relationships (QSARs) are the most widely used approach in drug design and have been applied successfully in the discovery of novel tyrosinase inhibitors [18, [43] [44] [45] [46] [47] [48] [49] . Hence, this method could constitute the principal "switch" for sequential workflow aiding to new lead compounds identification. The binary QSARs for tyrosinase inhibitors are described in previous reports [18, [43] [44] [45] [46] [47] [48] [49] , therefore a brief approximation will be discussed here. A first training set of 1072 compounds was collected with 526 chemicals classi ed as "active" (TIs) and 546 compounds as "inactive" (non-TIs). The molecular structures and properties were correlated with biological activity using TOMOCOMD-CARDD descriptors, 
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and different classification models were generated. These models enable the identification of TIs from inactive ones. In second place, the potency models were obtained using a learning set of 257 strong TIs and 141 moderate-to-weak compounds [19] [20] . The last ones would be used hierarchically with the models adjusted on the first database, for more complete description of tyrosinase inhibitory activity.
Afterward, we introduced other statistical techniques [quadratic discriminant analysis (QDA), binary logistic regression (BLR) and classification tree (CT) [20] ] and many machine learning approaches [support vector machine (SVM), artificial neural network (ANN), Bayesian networks (BNs), k-nearest neighbors (KNN) [19] ], which enhanced the performance of previous LDA-QSAR models in both database. Theses single classifiers can be used to make tyrosinase inhibitory activity depictions for new chemicals. However, many factors can affect the performance of those classifiers. Selecting the best available classifier is an option, but because the distribution of new chemicals that the classifier may meet during operation may vary (slightly or significantly depending on the application), this approach does not provide the best solution in all cases. Furthermore, because many classifiers are generally tried before a single classifier is selected, this approach also discards valuable information by ignoring the performance of all the other classifiers [50] .
By this aim, the combination of multiple classifiers has been proposed in the field of machine learning to improve the performance of the single classifier approaches [51] [52] [53] . These multiple classifier systems (MCS) are based on the combination of several classifiers such that their union achieves higher performance than the stand-alone classifiers. Hence, an ensemble of classifiers is a set of classifiers, whose individual classification decisions are combined in some way [54] . Many studies have demonstrated that ensembles often outperform their base models (the component models of the ensemble) if the base models perform well on novel examples and tend to make errors on different examples [55] .
In the case of tyrosinase inhibitor QSAR equations, to increase performance demands in modeling tyrosinase activity the individual models obtained were assembled in different multi-classifier systems (MCSs) to improve their performance classifiers for tyrosinase inhibitory activity prediction [21] .
For the Spectrum Collection, the compounds found by similarity searching were screened by QSAR (another positive design approach) using classification MCS based on average probability (AP) [21] to identify new TIs. Thus, 65/109 compounds were identified as active against tyrosinase enzyme. It is important to highlight that most of inactive compounds identified by QSAR were the last ones of the list of 109 compounds. The same occurs in the case of the Drugbank database were 119/131 were identified as actives. This justifies the selection of the cutoff value of similarity searching. The compounds identified by classification QSAR were sequentially screened by potency QSAR using boosting ensemble based on support vector machine [21] . This potency MCS identified 25 and 107 compounds from Spectrum Collection and Drugbank, respectively as strong TIs.
MODELING MOLECULAR INTERACTIONS SYS-TEMS
The next step was to use the molecular docking, that consists of posing each ligand into the binding site of the target. This gives a predicted binding mode for each database compound, together with a measure of the quality of the fit of the compound in the target binding site. This information is used to rank the compounds with a view to selecting and experimentally testing a small subset for biological activity [56] . The docking calculations of strong TIs identified by QSARs in the mentioned above studies were performed using the ICM™ docking module with the default setup as earlier mentioned [57] [58] [59] .
Preparations of the Inhibitors and Target Molecules
The 2D structure of the compound (in mol file format) was converted to 3D and energy minimized at the 3D space of ICM environment. The atom types using local chemical environment, Merck Molecular Force Field (MMFF) [60] [61] [62] [63] [64] [65] [66] formal charges and 3D topology were assigned. The lowest energy conformers of the compounds were then docked into the 3D space of the active site of the three dimensional structure of Tyrosinase (PDB ID: 3NQ1).
All the docking calculations were performed using the "interactive docking" menu at the ICM environment. After docking the stack of docking poses were checked visually. Multiple stack conformations were selected based on their docking energies, rmsd values (compared between the docked model and x-ray conformation) and similarities to closely related x-ray crystal structures from PDB. Then the best conformations for the compound were finally chosen, and then the binding energy was calculated using ICM script.
For each of the individual docked complexes the free energies of binding ( G cal ) between the protein and ligand was calculated using ICM script utilizing Equations 2 and 3 [67] .
Here, G H is the hydrophobic or cavity term, which accounts for the variation of water/non-water interface area. G el is the electrostatic term composed of coulombic ( G col ) interactions and desolvation ( G des-sol ) of partial charges transferred from an aqueous medium to a protein core environment. The G s is the entropic term which results from the decrease in the conformational freedom of functional groups buried upon complexation; and finally the C is a constant accounts for the change of entropy of the system due to the decrease of free molecules concentration (cratic factor), and loss of rotational/translational degrees of freedom [67] .
After preparation of docking process the strong TIs identified by QSARs were subsequently docked in the active site of the tyrosinase (PDB ID: 3NQ1) using the ICM program [57] . In this study, only the chemicals selected of the Spectrum Collection were used on the structure-based study. Docking is an effective method for prioritizing ligands with favorable interactions with the receptor and can also be seen as a positive design. For each case, the binding energy (BE) was achieved and used as score to binding mode prediction of the compounds. First, we calculated the BR for a set of strong, moderate-weak and inactive compounds with known activity against the tyrosinase. The docking molecular interaction process revealed that only one compound of the total of 25 selected by QSAR did not complement favorably the protein binding site. This result showed a good correspondence between QSAR and docking approaches.
POST-PROCESSING ANALYSIS
Some methodologies for post-processing after sequential virtual screening were assessed. In our case, we selected the k-NNCA (k-nearest neighbors cluster analysis) and k-MCA (k-means cluster analysis) algorithms [68] [69] to study the similarity/diversity among the retrieved active compounds and these latter ones with active compounds. This two types of Cluster Analysis (CA) were chosen because are a group of methods capable to recognize similarities among cases (objects) or among variables and single out some categories as a set of similar cases (or variables). Therefore it enables the selection of novel scaffold for tyrosinase inhibitors. Before carrying out the cluster processes, all the variables were standardized. In standardization, all values of selected variables (molecular descriptors) were replaced by standardized values, which are computed as follows: Std. score = (raw score -mean)/Std. deviation.
Finally, by a CA of the database active compounds and the retrieved ones plus a detailed visual inspection, for the case of Spectrum Collection, 19 out of 24 compounds were selected to be evaluated experimentally. It is important to note that within the six compounds removed, some have been reported in the literature activity against tyrosinase, such as hinokitiol [70] and angolensine [71] , while the Spectrum does not report itself. This fact confirmed the applicability of our protocol in the discovery of novel lead compounds anti-tyrosinase from large databases. Table 2 shows traditional uses and values of different "in silico" studies, the molecular structures of these compounds are given in Fig.  (3) .
On the case of Drugbank database, after cluster analysis and visual inspection we decided to select 32 compounds of the for enzyme assays. The structures of these compounds are shown in Table 3 and Table 4 shows traditional uses and values of different "in silico" studies for these drugs.
The flowchart in Fig. (1) is a schematic representation of the rational workflow sequential VS process with the number of hits reduced for each screening step in both databases. Using the sequential workflow, a total of fifty one putative novel TIs were successfully identified, which can be purchased and further evaluated in enzymatic experimental corroborations.
As it can be seen in both cases, many compounds identified as new TIs are already known drugs because and this avoids time-consuming to bring new drugs to market because re-discovered drugs that are already in use and its pharmacokinetic and toxicological properties are well-known [72] . This novel discovered drugs could be introduced into the market in the shortest time possible, thus accelerating the speed of discovery of new drugs for treating disorders of hyperpigmentation.
FUTURE TRENDS ON WORKFLOWS FOR BIO-ACTIVITY PREDICTION
Bioactivity or any type of property prediction has always be one of the challenges on data mining fields. In the case of selection of adequate anti-target activity the main arduous task are mainly focused in the correct identification of lead compounds or promissory high activity chemicals that could lead to drug-like compounds after examining its ADMET properties. Many predictive workflows has been showed in literature most of them focused on the use of 3D-QSAR COMFA, COMSIA and pharmacophore approaches together with docking studies [73] [74] . Because the drug discovery is a highly complex and costly process, the integration in innovation, knowledge, information, technologies, expertise, investments and management skills is required. In this way, the multistep VS can help identify bioactive substances from a large screening compound pool with limited experimental effort enabling to focus rapidly on the most promising candidate structures.
In the case of the specific workflow scenarios, some questions that remains unsolved were derived during writing this chapter, like the use of sub-workflows integrated by several Multi-Sequential Workflow responsible of each step for adequate drug-like properties, that is ADMET. Moreover the consideration of other aspects concerning to workflow like the accuracy, sequence of combination, the most better quantity of sub-workflows to be used, and thresholds established for any workflow should be examined.
Finally, these results offers a suitable alternative to the new era of open on-line chemical databases encouraging its use together with the ascending approaches based on the new technologies development such as massive computer calculations algorithms and cloud computing could have a overwhelming impact on virtual screening procedures based on ensemble workflows to solve several questions that are still in the route of drug discovery pipeline. Le-Thi-Thu et al.
Fig. (3).
Molecular structures of the identified virtual hits from Spectrum Collection by VS protocol. 
CONFLICT OF INTEREST
The authors confirm that this article content has no conflict of interest.
